XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 43.05

Change

+0.10 (+0.23)%

Market Cap

CAD 0.51B

Volume

670.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.54 (+0.38%)

CAD 18.40B
ZSP:CA BMO S&P 500

+0.31 (+0.35%)

CAD 16.97B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.10 (+0.16%)

CAD 11.11B
VUN:CA Vanguard US Total Market

+0.31 (+0.29%)

CAD 10.08B
XUS:CA iShares Core S&P 500 Index ETF

+0.17 (+0.34%)

CAD 7.80B
HXS:CA Global X S&P 500 Corporate Cla..

+0.29 (+0.35%)

CAD 4.30B
VSP:CA Vanguard S&P 500 CAD hedged

+0.15 (+0.16%)

CAD 3.59B
QUU:CA Mackenzie US Large Cap Equity ..

+0.01 (+0.00%)

CAD 3.40B
XUU:CA iShares Core S&P US Total Mark..

+0.27 (+0.45%)

CAD 3.20B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.53 (+1.03%)

CAD 3.15B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.82% 86% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.82% 88% B+ 81% B-
Trailing 12 Months  
Capital Gain 39.32% 74% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.32% 76% C+ 77% C+
Trailing 5 Years  
Capital Gain 103.07% 84% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.07% 86% B+ 82% B
Average Annual (5 Year Horizon)  
Capital Gain 14.07% 79% B- 79% B-
Dividend Return 14.87% 78% C+ 77% C+
Total Return 0.80% 20% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 14.76% 45% F 55% F
Risk Adjusted Return 100.77% 66% D+ 96% N/A
Market Capitalization 0.51B 53% F 59% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.